RESEARCH TRIANGLE PARK, N.C., Jan. 8, 2013 /PRNewswire/ -- Marken announced today the completion of its new, expanded pharmaceutical depot in Mexico City. The new state of the art facility is located closer to the Mexico City airport and provides a total of 1300 m² of GMP-compliant space for temperature controlled storage and distribution of clinical trial supplies. The recent expansion was a response to the significant client demand Marken is experiencing within that region.

"We are very pleased to announce the completion of this expansion which is a direct result of an increased demand for our services. In addition, we also enhanced our global project management team with experienced Project Leaders ensuring seamless set-up and coordination of all global clinical trial storage and distribution work. We will continue to push forward in enlarging our network to provide the most efficient and flexible solutions to our clients," said Gerit Offenhauser, Senior Vice President, Clinical Trials Distribution.

Marken's depots provide secure temperature controlled storage and distribution for pharmaceuticals, biologics, medical devices and diagnostic equipment. The new depot will supplement Marken's existing network of global depots in Germany, Singapore, USA and Argentina. Marken's depot network is connected through the Solo platform, a global state-of-the-art, 21 CFR part 11 validated, cloud based inventory management system which tracks dosages at the patient level.

Wes Wheeler, Chief Executive Officer of Marken said "Today's completion of our new Mexico depot is another important milestone in our global depot network expansion strategy. Through further continued investment in facilities and technologies, we will continue to ensure that our clients are served with full service, global clinical supply chain solutions and that we provide the highest quality courier and logistics services to our clients."

About Marken

Marken is the leading global clinical supply chain solutions provider dedicated to the pharmaceutical and life sciences industries, supporting over 49,000 clinical investigators in more than 150 countries. Marken integrates Depot and Logistics services into solutions that extend the reach of clinical trials to even the most remote treatment in naive geographies.

With more than 30 Kubernetes solutions in the marketplace, it's tempting to think Kubernetes and the vendor ecosystem has solved the problem of operationalizing containers at scale or of automatically managing the elasticity of the underlying infrastructure that these solutions n...

The deluge of IoT sensor data collected from connected devices and the powerful AI required to make that data actionable are giving rise to a hybrid ecosystem in which cloud, on-prem and edge processes become interweaved. Attendees will learn how emerging composable infrastructur...

When building large, cloud-based applications that operate at a high scale, it's important to maintain a high availability and resilience to failures. In order to do that, you must be tolerant of failures, even in light of failures in other areas of your application. "Fly two mis...

Machine learning has taken residence at our cities' cores and now we can finally have "smart cities." Cities are a collection of buildings made to provide the structure and safety necessary for people to function, create and survive. Buildings are a pool of ever-changing performa...

As Cybric's Chief Technology Officer, Mike D. Kail is responsible for the strategic vision and technical direction of the platform. Prior to founding Cybric, Mike was Yahoo's CIO and SVP of Infrastructure, where he led the IT and Data Center functions for the company. He has more...